Robert LeBoyer

Stock Analyst at Noble Capital Markets

(0.87)
# 2264
Out of 5,358 analysts
20
Total ratings
43.75%
Success rate
11.40%
Average return
16 Stocks
Name Action PT Current % Upside Ratings Updated
TNXP Tonix Pharmaceutical...
Reiterates: Outperform
70 70
40.62 72.33% 2 Mar 20, 2025
NTRB Nutriband
Initiates Coverage On: Outperform
13
7.77 67.31% 1 Jan 22, 2025
GOVX Geovax Labs
Maintains: Outperform
6 10
1.1 809.09% 2 Aug 19, 2024
UNCY Unicycive Therapeuti...
Initiates Coverage On: Outperform
6
0.76 689.47% 1 Feb 14, 2024
CVKD Cadrenal Therapeutic...
Initiates Coverage On: Outperform
60
14.99 300.27% 1 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
10
3.07 225.73% 1 Sep 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
14
1.79 682.12% 1 Feb 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Sep 20, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
150
n/a n/a 1 Oct 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
8
0.67 1094.03% 2 Aug 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
120
0.33 36263.64% 1 Jan 25, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Oct 5, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
8.29 44.75% 1 Sep 28, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
825000
n/a n/a 1 Aug 24, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Apr 10, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
3.01 398.34% 2 Mar 8, 2018